How Many Doses Vial NAD+? (Reconstitution & Dosing Math) |

How Many Doses Vial NAD+? (Reconstitution & Dosing Math) | Real Peptides

A 500mg NAD+ vial purchased from a research-grade supplier doesn't arrive ready to inject. It's a lyophilised powder that requires reconstitution with bacteriostatic water before use. The number of doses you can extract depends on two variables: how much bacteriostatic water you add (typically 2–10mL) and how much solution you draw per injection (typically 0.2–1.0mL per dose). This isn't pre-portioned like an insulin pen. You control the concentration, which means you control how many doses the vial yields.

We've guided researchers through this calculation hundreds of times. The confusion arises because most guides explain the process but skip the actual math. Leaving researchers to reverse-engineer dosing from vague instructions.

How many doses does one vial of NAD+ contain?

A 500mg NAD+ vial typically yields 10–25 research injections depending on reconstitution volume and individual dose size. If you reconstitute 500mg in 5mL of bacteriostatic water and draw 0.5mL per injection at 50mg dose strength, you'll extract 10 doses. If you reconstitute the same vial in 10mL and draw 0.4mL per injection at 20mg dose strength, you'll extract 25 doses. The vial size determines total milligrams available. Your reconstitution ratio determines concentration and dose count.

Direct Answer: The Reconstitution Math Most Guides Skip

Yes, the answer depends on protocol. But the calculation itself is universal. One common misconception: researchers assume the vial size (500mg, 1000mg) directly translates to a fixed number of doses. It doesn't. The vial contains total milligrams of lyophilised NAD+. How you dilute that powder determines the final concentration, and concentration determines how much solution you need to draw to reach your target dose in milligrams.

This article covers the reconstitution math for standard vial sizes (500mg, 1000mg), the relationship between bacteriostatic water volume and final concentration, the dose ranges used in published NAD+ research, and the storage considerations that affect how many usable doses you can extract before degradation occurs.

Vial Sizes and Standard Reconstitution Volumes

NAD+ (nicotinamide adenine dinucleotide) vials are sold by total milligram content. Typically 500mg, 1000mg, or 2000mg of lyophilised powder per vial. The powder itself is inert until reconstituted with bacteriostatic water, which dissolves the compound into an injectable solution. The volume of water you add determines the final concentration in mg/mL, which in turn determines how much solution you need to draw to reach a specific dose.

Standard reconstitution volumes for a 500mg vial range from 2mL to 10mL of bacteriostatic water. A 2mL reconstitution yields 250mg/mL concentration. Meaning each 0.2mL (20 units on an insulin syringe) contains 50mg of NAD+. A 10mL reconstitution yields 50mg/mL concentration. Meaning you'd need to draw 1.0mL (100 units) to reach the same 50mg dose. The first option (higher concentration, smaller volume) requires fewer injections to deplete the vial but uses more concentrated solution per injection. The second option (lower concentration, larger volume) spreads the same total milligrams across more injections at lower concentration per mL.

Our experience with research-grade NAD+ preparations shows that 5mL reconstitution (yielding 100mg/mL) is the most common middle-ground choice. It balances concentration convenience with injection volume comfort. At 100mg/mL, a 0.5mL injection delivers 50mg, and a 500mg vial yields exactly 10 injections at that dose strength.

Dose Strength and Injection Frequency in Published Research

The number of doses you extract from a vial depends on how many milligrams per injection your protocol requires. Published NAD+ research uses a wide range. Subcutaneous and intramuscular protocols typically range from 20mg to 100mg per injection, administered 2–3 times weekly or daily depending on the study design. Intravenous NAD+ studies use significantly higher doses (250mg to 1000mg per infusion), but those protocols require multi-vial pooling and are outside the scope of standard single-vial reconstitution.

A 500mg vial reconstituted in 5mL bacteriostatic water yields 100mg/mL concentration. At this concentration, a 50mg dose requires drawing 0.5mL per injection. The vial contains 10 total doses. A 25mg dose requires drawing 0.25mL per injection. The vial contains 20 total doses. A 100mg dose requires drawing 1.0mL per injection. The vial contains 5 total doses. The relationship is linear: total milligrams in the vial divided by milligrams per dose equals number of doses available.

Researchers using daily injection protocols at 50mg per dose will deplete a 500mg vial in 10 days. Researchers using twice-weekly protocols at the same dose strength will deplete the vial in 5 weeks. The frequency of administration doesn't change the total number of doses. It changes how quickly those doses are consumed. This matters for storage planning, because reconstituted NAD+ has a finite stability window even under refrigeration.

Reconstitution Math: The Universal Formula

The calculation for determining doses per vial follows this sequence: (1) identify total milligrams in the vial, (2) identify reconstitution volume in mL, (3) calculate concentration as mg/mL by dividing total mg by total mL, (4) identify target dose in mg per injection, (5) calculate required volume per injection by dividing target dose mg by concentration mg/mL, (6) calculate total number of doses by dividing total vial volume by volume per injection.

Example: A 1000mg vial reconstituted in 10mL bacteriostatic water yields 100mg/mL concentration. If your protocol requires 50mg per injection, divide 50mg by 100mg/mL to get 0.5mL required per injection. The vial contains 10mL total, so divide 10mL by 0.5mL per injection to get 20 total doses. The same vial at 25mg per dose yields 40 doses (10mL ÷ 0.25mL per injection). The same vial at 100mg per dose yields 10 doses (10mL ÷ 1.0mL per injection).

We've found that most reconstitution errors occur at step 5. Researchers correctly calculate concentration but then draw the wrong volume because they confuse milligrams with millilitres. An insulin syringe is marked in units, where 100 units equals 1.0mL. If you need to draw 0.5mL at 100mg/mL concentration to get a 50mg dose, you draw to the 50-unit mark on the syringe. Not the 50mg mark, because there is no 50mg mark. The syringe measures volume, not mass.

NAD+ Vial Comparison: Doses Per Vial by Size and Protocol

Key Takeaways

• A 500mg NAD+ vial yields 10–25 research injections depending on reconstitution volume and individual dose strength. The vial's milligram content is fixed, but concentration and dose count are user-controlled.
• Reconstitution concentration is calculated as total milligrams divided by total millilitres of bacteriostatic water added. A 500mg vial in 5mL yields 100mg/mL.
• Dose count equals total vial volume divided by volume drawn per injection. A 10mL vial drawn at 0.5mL per dose yields 20 total doses.
• Reconstituted NAD+ remains stable for approximately 28 days when stored at 2–8°C in the original sterile vial. Protocols requiring more than 28 doses from a single vial should use lyophilised powder storage and reconstitute in smaller batches.
• Most reconstitution errors occur when researchers confuse syringe units (volume measurement) with milligram dosing. An insulin syringe's 50-unit mark represents 0.5mL of solution, not 50mg of compound.

What If: NAD+ Dosing Scenarios

What If I Need 30 Doses From a Single Vial — Is That Possible?

Yes, but only if your dose strength is low enough and your vial size is large enough. A 1000mg vial reconstituted in 10mL at 100mg/mL concentration yields 30 doses if you draw 0.33mL per injection (33mg per dose). A 2000mg vial at the same concentration yields 60 doses at 33mg each. The constraint is the 28-day refrigerated stability window. If your injection frequency is twice weekly, 30 doses would take 15 weeks to deplete, which exceeds the safe storage period. In that case, reconstitute half the powder in a smaller volume, store the remaining lyophilised powder at −20°C, and reconstitute the second batch when the first is depleted.

What If I Reconstituted With Too Much Water — Can I Fix It?

No. Once bacteriostatic water is added, the concentration is set. If you intended to reconstitute 500mg in 5mL but accidentally added 10mL, your concentration is now 50mg/mL instead of 100mg/mL. You can't remove water from the vial without contaminating the solution. Your only option is to adjust your drawing volume to compensate. If you wanted 50mg per dose, you now need to draw 1.0mL instead of 0.5mL. The total number of doses remains the same (the vial still contains 500mg total), but each injection volume doubles.

What If the Vial Contains Less Solution Than Expected After Reconstitution?

The reconstituted solution volume should equal the bacteriostatic water volume you added. The lyophilised powder dissolves without significantly increasing total liquid volume. If you added 5mL of water and the vial appears to contain only 4.5mL, either (1) you didn't inject the full 5mL, or (2) some solution is trapped in the lyophilised cake and requires additional gentle swirling to fully dissolve. Never shake NAD+ vials vigorously. It denatures the compound. Swirl gently until all powder dissolves and the solution is clear.

The Blunt Truth About NAD+ Vial Yield

Here's the honest answer: the marketed "vial size" tells you total milligrams available. Nothing more. A "500mg vial" doesn't come with 10 pre-measured doses, 20 doses, or any fixed number. You create the doses yourself by choosing a reconstitution volume and a drawing volume per injection. If you reconstitute carelessly or draw inconsistent volumes, you'll either run out of solution earlier than expected or waste milligrams at the bottom of an under-utilised vial.

The single biggest mistake researchers make is reconstituting the entire vial at once without considering their injection frequency. If you're running a twice-weekly protocol and you reconstitute a 2000mg vial in 10mL, you have 20 doses at 100mg each. But that's 10 weeks of injections, which exceeds the 28-day refrigerated stability window by more than double. The last several doses will have degraded significantly. Reconstitute only what you'll use within 28 days, and store the remaining lyophilised powder at −20°C until needed.

Storage and the Real Limit on Usable Doses

The shelf life of lyophilised NAD+ powder stored at −20°C is typically 12–24 months, but once reconstituted with bacteriostatic water, the stability window drops to approximately 28 days at 2–8°C. This is the hard constraint on how many usable doses you can extract from a single vial. Not the total milligrams, not the reconstitution math, but the degradation timeline. NAD+ is particularly sensitive to temperature excursions and light exposure, both of which accelerate oxidative breakdown of the nicotinamide-ribose bond.

If your protocol requires 50mg twice weekly, you'll use 400mg over 28 days (eight injections at 50mg each). Reconstituting a 500mg vial means you'll have 100mg remaining when the stability window closes. That's two wasted doses unless you accelerate your protocol near the end of the window. A better approach: reconstitute 400mg worth of solution (4mL at 100mg/mL if drawing from a larger vial) and leave the remaining powder in lyophilised form for the next batch.

Researchers working with our high-purity peptide preparations consistently report better dose-to-dose consistency when they reconstitute in smaller, protocol-matched batches rather than reconstituting entire vials upfront. The trade-off is reconstitution frequency, but the gain is zero waste and maximum compound stability across the full protocol duration.

The relationship between vial size and usable doses isn't just math. It's math constrained by biochemistry. A 2000mg vial can theoretically yield 80 doses at 25mg each, but only if you're injecting daily and depleting the vial within the stability window. For most research applications, vial size should match protocol duration, not just total milligram requirements.

faqs

[
{
"question": "How many doses are in a 500mg vial of NAD+?",
"answer": "A 500mg vial yields 10–25 doses depending on reconstitution volume and dose strength. If reconstituted in 5mL bacteriostatic water at 100mg/mL concentration, you'll extract 10 doses at 50mg each (0.5mL per injection), 20 doses at 25mg each (0.25mL per injection), or 5 doses at 100mg each (1.0mL per injection). The vial contains a fixed 500mg total. Your protocol determines how that total is divided across injections."
},
{
"question": "Can I use a single NAD+ vial for a full month of daily injections?",
"answer": "Yes, if the vial size and dose strength align with your protocol and the reconstituted solution remains within the 28-day refrigerated stability window. A 1000mg vial at 33mg per dose yields 30 injections. Exactly enough for daily administration over one month. Reconstitute in 10mL bacteriostatic water (100mg/mL concentration) and draw 0.33mL per injection. Store at 2–8°C and use within 28 days of reconstitution."
},
{
"question": "What happens if I draw inconsistent volumes from the vial. Does it affect total doses?",
"answer": "Yes. Inconsistent drawing volumes mean some injections deliver more milligrams than intended and others deliver less, which can deplete the vial faster than expected or leave unusable solution at the end. If you're targeting 50mg per dose at 100mg/mL concentration, every injection should draw exactly 0.5mL. Drawing 0.6mL wastes 10mg per injection, reducing your 10-dose vial to roughly 8 usable doses. Use an insulin syringe with clear unit markings and draw to the same mark every time."
},
{
"question": "How long does reconstituted NAD+ remain stable. And does that limit usable doses?",
"answer": "Reconstituted NAD+ stored at 2–8°C in a sterile vial remains stable for approximately 28 days before oxidative degradation reduces potency. This is the real constraint on usable doses. If your vial contains 40 theoretical doses but your protocol only calls for twice-weekly injections, you'll only use 8 doses within the stability window. The remaining 32 doses will degrade. For protocols longer than 28 days, reconstitute powder in smaller batches and store unused lyophilised powder at −20°C."
},
{
"question": "Can I reconstitute a 1000mg vial in less than 10mL to get higher concentration?",
"answer": "Yes. Reconstituting 1000mg in 5mL yields 200mg/mL concentration, which allows you to deliver higher doses in smaller injection volumes. A 100mg dose would require only 0.5mL instead of 1.0mL. The trade-off is that higher-concentration solutions can be more viscous and slightly more uncomfortable to inject subcutaneously. Most researchers find 100mg/mL to be the optimal balance between concentration convenience and injection comfort."
},
{
"question": "What is the difference between NAD+ vial sizes. Does a 1000mg vial last twice as long as a 500mg vial?",
"answer": "Only if your dose strength and injection frequency remain constant. A 1000mg vial contains exactly twice the total milligrams of a 500mg vial, so at the same dose per injection, it yields twice the number of doses. A 500mg vial at 50mg per dose yields 10 injections; a 1000mg vial at the same dose yields 20 injections. However, if you increase your dose strength when switching to the larger vial, the relationship changes. A 1000mg vial at 100mg per dose yields the same 10 injections as a 500mg vial at 50mg per dose."
},
{
"question": "Do I need to refrigerate NAD+ immediately after reconstitution?",
"answer": "Yes. Reconstituted NAD+ should be refrigerated at 2–8°C within 30 minutes of mixing to minimize oxidative degradation. The nicotinamide-adenine dinucleotide bond is temperature-sensitive and begins breaking down at room temperature within hours. Lyophilised powder can be stored at −20°C for 12–24 months, but once bacteriostatic water is added, the stability window drops to 28 days even under refrigeration. Never freeze reconstituted NAD+. Ice crystal formation can denature the compound."
},
{
"question": "How do I calculate the correct syringe volume if my target dose is 75mg and my concentration is 100mg/mL?",
"answer": "Divide target dose in milligrams by concentration in mg/mL to get the required volume in millilitres. For a 75mg dose at 100mg/mL concentration, divide 75mg by 100mg/mL to get 0.75mL required volume. On an insulin syringe marked in units (where 100 units equals 1.0mL), 0.75mL corresponds to the 75-unit mark. Draw to that line, and you'll deliver exactly 75mg per injection."
},
{
"question": "Can I mix two different peptides in the same vial to save space?",
"answer": "No. Mixing different peptides in the same vial risks cross-contamination, unpredictable interactions, and dosing errors. Each peptide should be reconstituted in its own sterile vial using fresh bacteriostatic water. If you're running multi-peptide protocols, label each vial clearly with the peptide name, reconstitution date, and concentration. Drawing from the wrong vial or confusing concentrations can result in significant underdosing or overdosing."
},
{
"question": "What should I do with the remaining solution if I can't use all doses within 28 days?",
"answer": "Discard it. Degraded NAD+ won't harm you, but it won't deliver the intended research outcome either. The 28-day refrigerated stability window is a biochemical limitation, not a regulatory suggestion. If your protocol requires fewer doses than the vial yields within that window, reconstitute only the portion you'll use and store the remaining lyophilised powder at −20°C. Alternatively, adjust your vial size to match your protocol duration. A 500mg vial is better suited to short-term protocols than a 2000mg vial."
}
]